✦ LIBER ✦

Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease: A southeastern cancer study group trial

✍ Scribed by Richard A. Gams; George A. Omura; Enrique Velez-Garcia; Robert Kellermeyer; Marilyn Raney; Alfred A. Bartolucci

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 436 KB
Volume: 58
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19861101)58:9<1963::aid-cncr2820580902>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide in combination as first-line c

Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A cancer and leukemia group B study

✍ Jeffrey J. Kirshner; James R. Anderson; Barbara Parker; Maurice Barcos; M. Rober 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

Background. In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease. Thirty-six evaluable patients were treated with two or three courses of methotrexate, vincristine, prednisone, leucovorin, etoposide, and cyclophos

The superiority of CCNU in the treatment

The superiority of CCNU in the treatment of advanced hodgkin's disease: Cancer and leukemia group b study

✍ Heine H. Hansen; Oleg S. Selawry; Thomas F. Pajak; Charles L. Spurr; Geoffrey Fa 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

A comparative clinical assessment of com

A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinoma

✍ Michael J. O'Connell; THE GASTROINTESTINAL TUMOR STUDY GROUP 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

Clinical trial of VP 16–213 (NSC 141540)

Clinical trial of VP 16–213 (NSC 141540) I.V. Twice weekly in advanced neoplastic disease a study by the cancer and leukemia group B

✍ Nis I. Nissen; Thomas F. Pajak; Louis A. Leone; Clara D. Bloomfield; B. J. Kenne 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB

Advanced hodgkin disease with large medi

Advanced hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy : A study of 82 patients from the groupes d'etudes des lymphomes de l'adulte h89 trial

✍ Pauline Brice; Philippe Colin; Françoise Berger; Eric de Kerviler; Marine Diviné 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views